Belimumab in refractory organizing pneumonia associated with systemic lupus erythematosus: a case report.

Abstract:

:Organizing pneumonia is an inflammatory lung entity that presents with a huge variety of clinical, radiological and pathological patterns. Organizing pneumonia can be idiopathic or secondary to other diseases. Corticosteroid therapy is usually the first-line treatment showing clinical improvement in most cases. This report presents the case of a 56-year-old woman with systemic lupus erythematosus who was diagnosed with an organizing pneumonia and showed a poor response to steroid and azathioprine treatment. We considered the use of belimumab, which resulted in excellent clinical and radiological outcomes.

journal_name

Lupus

journal_title

Lupus

authors

Giménez AR,Pastrana DB,Huaranga MAR,Izquierdo JR,Cabrera B,García AN,Rodríguez CCR

doi

10.1177/0961203319835320

subject

Has Abstract

pub_date

2019-04-01 00:00:00

pages

565-568

issue

4

eissn

0961-2033

issn

1477-0962

journal_volume

28

pub_type

杂志文章

相关文献

LUPUS文献大全
  • AVEMAR (a new benzoquinone-containing natural product) administration interferes with the Th2 response in experimental SLE and promotes amelioration of the disease.

    abstract::The potential of oral treatment with AVEMAR (AVEMAR), a new benzoquinone-containing fermentation product of wheat germ, on features of experimental systemic lupus erythematosus (SLE) in naive mice, induced by idiotypic manipulation, was studied. We assessed the effect of AVEMAR on the profile of autoantibody productio...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120301682430203

    authors: Ehrenfeld M,Blank M,Shoenfeld Y,Hidvegi M

    更新日期:2001-01-01 00:00:00

  • The SLICC/ACR damage index: progress report and experience in the field.

    abstract::The SLICC/ACR damage index for SLE was developed to assess accumulated damage since the onset of the disease. The damage includes non-reversible changes in organs and systems affected by the disease process itself, its therapy, or inter-current illness. This paper describes the development of the damage index, its val...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399680411335

    authors: Gladman DD,Urowitz MB

    更新日期:1999-01-01 00:00:00

  • Use of monoclonal antibodies to dissect specificity and pathogenesis of antiphospholipid antibodies.

    abstract::Monoclonal antiphospholipid antibodies (aPL) have been utilized to dissect the relationship between their sequence, structure, binding and biological properties relevant to the pathogenesis of the antiphospholipid syndrome. In particular, sequence analysis of aPL has highlighted the clustering of certain amino acid re...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309360809

    authors: Lambrianides A,Giles IP

    更新日期:2010-04-01 00:00:00

  • Antiphospholipid antibodies in an in vivo thrombosis model in mice.

    abstract::The mouse model described in this study offers a unique method of determining the characteristics and mechanism(s) of action of aCL antibodies in thrombosis in vivo. In addition, this animal model enables the study of the kinetics of formation and dissolution of thrombus, as well as clot area, to be studied in a dynam...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339400300408

    authors: Pierangeli SS,Harris EN

    更新日期:1994-08-01 00:00:00

  • Impairment of quality of life in patients with antiphospholipid syndrome.

    abstract:OBJECTIVES:Health-related quality of life (HRQoL) has not been fully explored in antiphospholipid syndrome (APS); therefore, we compared HRQoL between APS patients and the general population and assessed the impact of thromboembolic history. METHODS:HRQoL was measured in a multicentre cohort study by the Medical Outco...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203315580871

    authors: Zuily S,Rat AC,Regnault V,Kaminsky P,Mismetti P,Ninet J,Baillet N,Magy-Bertrand N,Pasquali JL,Lambert M,Pasquier E,Lorcerie B,Lecompte T,Guillemin F,Wahl D,TAC(I)T investigators.

    更新日期:2015-10-01 00:00:00

  • Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS).

    abstract:BACKGROUND:Ferritin is an iron storage protein considered also as an acute phase reactant with high levels in various inflammatory conditions. Recently, a plausible role for ferritin in the pathogenesis of immune-mediated and especially autoimmune diseases has been suggested. However, the link between ferritin and the ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313504633

    authors: Agmon-Levin N,Rosário C,Katz BS,Zandman-Goddard G,Meroni P,Cervera R,Stojanovich L,Blank M,Pierangeli S,Praprotnik S,Meis Ed,Seguro LP,Ruffatti A,Pengo V,Tincani A,Doria A,Shoenfeld Y

    更新日期:2013-11-01 00:00:00

  • Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.

    abstract:OBJECTIVE:The objective of this paper is to evaluate whether the different International Society of Nephrology/Renal Pathology Society (ISN/RPS) classes of proliferative lupus nephritis (LN) have a distinct baseline presentation, short-term response to immunosuppression (IS) and long-term prognosis. METHODS:Ninety-eig...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313514623

    authors: Vandepapelière J,Aydin S,Cosyns JP,Depresseux G,Jadoul M,Houssiau FA

    更新日期:2014-02-01 00:00:00

  • The association of malignancy with SLE: an analysis of 150 patients under long-term review.

    abstract::We describe seven patients who developed malignancy before, after or at the onset of systemic lupus erythematosus (SLE). They comprise three cases of breast adenocarcinoma, two cases of Hodgkin's lymphoma, and one each of cholangiocarcinoma and thymoma. Only one of this group had been treated with cytotoxic agents, an...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339300200309

    authors: Menon S,Snaith ML,Isenberg DA

    更新日期:1993-06-01 00:00:00

  • Relationship between clinical features and binding domains of anti-prothrombin autoantibodies in patients with systemic lupus erythematosus and antiphospholipid syndrome.

    abstract::Autoantibodies against prothrombin, including lupus anticoagulant antibodies (LAC), have been identified in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). To identify the epitopes of LAC in patients with SLE and APS, we analyzed B cell epitopes of anti-prothrombin Abs. Prothrombi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678840963

    authors: Akimoto T,Akama T,Kono I,Sumida T

    更新日期:1999-01-01 00:00:00

  • Swallowing disturbance due to isolated vagus nerve involvement in systemic lupus erythematosus.

    abstract::Neuropsychiatric lupus is a well-recognized complication of systemic lupus erythematosus (SLE) and encompasses a wide variety of neurological manifestations. Although isolated cranial nerve involvement is rare, it can cause significant morbidity and disability. This report describes a case with isolated vagus nerve in...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307080632

    authors: Yu KH,Yang CH,Chu CC

    更新日期:2007-01-01 00:00:00

  • Mycophenolate mofetil in nonlupus glomerulonephropathy.

    abstract::Mycophenolate mofetil (MMF) initially found widespread use in the immunoprophylaxis of rejection in organ transplantation. It has subsequently been used in lupus glomerulonephritis, where early studies have shown it to be effective in induction and maintenance therapy. The randomized studies have mostly studied small ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203305lu2116oa

    authors: Karim MY,Abbs IC

    更新日期:2005-01-01 00:00:00

  • Infant perinatal thrombosis and antiphospholipid antibodies: a review.

    abstract::Perinatal thrombosis in infants born to mothers with antiphospholipid antibodies (aPL) is a rare event, but with risk of death or severe sequelae. We analysed 16 infants with such perinatal thrombosis reported in the literature in the last 20 years. Thromboses were arterial (13/16), mostly strokes (8/16). Hydrops feta...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203307079039

    authors: Boffa MC,Lachassinne E

    更新日期:2007-01-01 00:00:00

  • Evaluation of belimumab treatment in patients with systemic lupus erythematosus in a clinical practice setting: Results from a 24-month OBSErve study in Argentina.

    abstract:OBJECTIVE:To describe clinical effectiveness of belimumab for systemic lupus erythematosus (SLE) in real-world practice in Argentina. METHODS:This retrospective, observational study analysed medical record data of patients with SLE treated with belimumab in 15 centres in Argentina. Primary endpoint: overall clinical r...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320947814

    authors: Babini A,Cappuccio AM,Caprarulo C,Casado G,Eimon A,Figueredo H,García MA,Magri S,Mannucci P,Perez Rodriguez S,Pons-Estel BA,Velozo EJ,Iglesias-Rodriguez M,Streger G

    更新日期:2020-10-01 00:00:00

  • Antiphospholipid syndrome: clinical and therapeutic aspects.

    abstract::The purpose of the present study was to evaluate patients with the antiphospholipid syndrome with particular attention to their initial clinical features, final diagnoses and the course of thrombotic events in association with therapy. The methodology applied was the following: retrospective analysis of 30 patient fil...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339400300206

    authors: Vlachoyiannopoulos PG,Tsiakou E,Chalevelakis G,Raptis SA,Moutsopoulos HM

    更新日期:1994-04-01 00:00:00

  • Three cases of spondyloenchondrodysplasia (SPENCD) with systemic lupus erythematosus: a case series and review of the literature.

    abstract::Spondyloenchondrodysplasia (SPENCD) is a rare autosomal recessive skeletal dysplasia caused by recessive mutations in the ACP5 gene, and it is characterized by the persistence of chondroid tissue islands within the bone. The clinical spectrum of SPENCD includes neurological involvement and immune dysfunction, such as ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203316629000

    authors: Bilginer Y,Düzova A,Topaloğlu R,Batu ED,Boduroğlu K,Güçer Ş,Bodur I,Alanay Y

    更新日期:2016-06-01 00:00:00

  • Antibodies to M-type phospholipase A2 receptor (PLA2R) in membranous lupus nephritis.

    abstract:BACKGROUND:Antibodies to M-type phospholipase A2 receptor (a-PLA2R) have been identified in most patients with idiopathic membranous nephropathy, but the prevalence in membranous lupus nephritis (MLN) is still unclear. The objective of this study was to assess the prevalence of a-PLA2R antibodies in a large cohort of p...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319828521

    authors: Garcia-Vives E,Solé C,Moliné T,Alvarez-Rios AM,Vidal M,Agraz I,Ordi-Ros J,Cortés-Hernández J

    更新日期:2019-03-01 00:00:00

  • The anti-thrombotic effects of vitamin D and their possible relationship with antiphospholipid syndrome.

    abstract::The importance of the immunomodulatory effects of vitamin D has recently been associated with autoimmune and chronic inflammatory diseases. Vitamin D deficiency has been linked to the development of autoimmune conditions. Antiphospholipid syndrome is an autoimmune disease characterized by thrombotic events and obstetr...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203318801520

    authors: García-Carrasco M,Jiménez-Herrera EA,Gálvez-Romero JL,Mendoza-Pinto C,Méndez-Martínez S,Etchegaray-Morales I,Munguía-Realpozo P,Vázquez de Lara-Cisneros L,Santa Cruz FJ,Cervera R

    更新日期:2018-12-01 00:00:00

  • Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome.

    abstract::The aim of this study was to evaluate traditional risk factors for coronary artery disease (CAD), homocysteine, anti-oxidized low-density lipoprotein (anti-oxLDL), anti-lipoprotein lipase (anti-LPL) and endothelin-1 (ET-1) in patients with primary anti-phospholipid syndrome (APS), furthermore verify possible associati...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307081847

    authors: de Souza AW,Silva NP,de Carvalho JF,D'Almeida V,Noguti MA,Sato EI

    更新日期:2007-01-01 00:00:00

  • The lupus patient traveller: a guide to the rheumatologist.

    abstract::With an increasing number of international journeys occurring daily, there is also an increase in the need for appropriate medical advice for patients who will undertake such travel. In this context, the lupus patient presents a great challenge to the rheumatologist. However, the demand for such information by patient...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203319888688

    authors: Oliveira DS,Hillal JPD,Cordova DDP,de Araujo DB

    更新日期:2019-12-01 00:00:00

  • High prevalence of infections in patients with systemic lupus erythematosus and pulmonary haemorrhage.

    abstract::The main objective of this study is to describe the presence of infections in patients with pulmonary haemorrhage and systemic lupus erythematosus. Patients with systemic lupus erythematosus and pulmonary haemorrhage were thoroughly evaluated in the first 48 hours with imaging plus bronchoscopy and bronchoalveolar flu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307086930

    authors: Rojas-Serrano J,Pedroza J,Regalado J,Robledo J,Reyes E,Sifuentes-Osornio J,Flores-Suárez LF

    更新日期:2008-04-01 00:00:00

  • Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production.

    abstract::Tumour necrosis factor (TNFalpha) is a cytokine with a wide range of diverse and at times paradoxical effects. These include immunoregulatory, lymphoid organogenesis and pro-inflammatory effects. In recent years, TNFalpha has become a focus of interest more for its inflammatory effects in a number of chronic autoimmun...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203302lu306rr

    authors: Mageed RA,Isenberg DA

    更新日期:2002-01-01 00:00:00

  • Severe tissue trauma triggers the autoimmune state systemic lupus erythematosus in the MRL/++ lupus-prone mouse.

    abstract::Tissue damage associated with a severe injury can result in profound inflammatory responses that may trigger autoimmune development in lupus-prone individuals. In this study, we investigated the role of a large full-thickness cutaneous burn injury on the early onset of autoimmune disease in lupus-prone MRL/++ mice. MR...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308097479

    authors: Anam K,Amare M,Naik S,Szabo KA,Davis TA

    更新日期:2009-04-01 00:00:00

  • Systemic lupus erythematosus patients in the low-latitude plateau of China: altitudinal influences.

    abstract::The current study was to investigate the features of hospitalized patients with systemic lupus erythematosus (SLE) at different altitudes. The correlation between SLE activity and altitudinal variations was also explored. Medical records of 1029 patients were retrospectively reviewed. Activity of SLE in each organ sys...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314544186

    authors: Qian G,Ran X,Zhou CX,Deng DQ,Zhang PL,Guo Y,Luo JH,Zhou XH,Xie H,Cai M

    更新日期:2014-12-01 00:00:00

  • Olanzapine-induced neutropenia in a patient with systemiclupus erythematosus: a role of FcγRIIIb polymorphism?

    abstract::In this study, we report the case of a Chinese patient with systemic lupus erythematosus (SLE) who developed neutropenia after treatment by olanzapine for the SLE-related psychiatric symptoms. The relationship between agranulocytosis, SLE and olanzapine is still unknown. Fcγ receptor IIIb (FcγRIIIb) is a low-affinity ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311415889

    authors: Salviati M,Ortona E,Colasanti T,Francia A,Pontecorvo S,Delle Chiaie R

    更新日期:2012-01-01 00:00:00

  • Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy.

    abstract::The pathogenesis and therapy of shrinking lungs syndrome in patients with systemic lupus erythematosus remains controversial. It has been previously reported that corticosteroid treatment can be effective. We report a patient with shrinking lungs syndrome who presented a good response to inhaled beta-agonist therapy. ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600413

    authors: Muñoz-Rodríguez FJ,Font J,Badia JR,Miret C,Barberà JA,Cervera R,Ingelmo M

    更新日期:1997-01-01 00:00:00

  • Analysis of JC virus DNA in NPSLE patients treated with different immunomodulatory agents.

    abstract:OBJECTIVE:The objective of this report is to assess the presence and viral load of JC polyomavirus (JCV) DNA in cerebrospinal fluid (CSF) and plasma from neuropsychiatric systemic lupus erythematosus (NPSLE) patients in comparison to controls and to investigate if different types of immunosuppressive treatments were co...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312470977

    authors: Iacobaeus E,Hopia L,Khademi M,Lundén M,Hammarin AL,Svenungsson E,Andersson M

    更新日期:2013-03-01 00:00:00

  • Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention.

    abstract::Systemic lupus erythematosus (SLE) is an autoantibody and immune complex mediated disease. However, it is the ensuing inflammatory process that leads to irreversible organ damage. In fact several murine models of SLE suggest that this inflammatory organ damage can be prevented even in the presence of autoantibodies. G...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203303lu1024oa

    authors: Aringer M,Smolen JS

    更新日期:2004-01-01 00:00:00

  • Sustained remission of lupus nephritis.

    abstract::The aim of this study was to describe the clinical course of patients with lupus nephritis (LN) who attain a sustained remission (SR) and identify predictors of SR. A retrospective study of patients with biopsy-proven LN were followed for up to 10 years. SR was defined as normal renal function, urine protein <0.5g/day...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203306lu2271oa

    authors: Barber CE,Geldenhuys L,Hanly JG

    更新日期:2006-01-01 00:00:00

  • Update on therapy--thalidomide in the treatment of lupus.

    abstract::Thalidomide has been shown to be an effective treatment for cutaneous forms of lupus erythematous refractory to other therapies. Thalidomide has very serious side effects, including teratogenicity and neuropathy, which limit its clinical use in lupus to such severe refractory cases. Efficacy has been confirmed in seve...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120301677213822

    authors: Karim MY,Ruiz-Irastorza G,Khamashta MA,Hughes GR

    更新日期:2001-01-01 00:00:00

  • Impaired sexual function in women with systemic lupus erythematosus: a cross-sectional study.

    abstract:OBJECTIVE:The objectives of this paper are to compare sexual function and distress in women with systemic lupus erythematosus (SLE) and in healthy controls; to determine the association between disease characteristics, quality of life, psychopathology and sexual function; and to compare sexual function and distress of ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313500370

    authors: García Morales M,Callejas Rubio JI,Peralta-Ramírez MI,Henares Romero LJ,Ríos Fernández R,Camps García MT,Navarrete Navarrete N,Ortego Centeno N

    更新日期:2013-09-01 00:00:00